<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>132(23)</volume><submitter>Linderman SL</submitter><funding>NIAID NIH HHS</funding><funding>Emory University</funding><funding>NIH</funding><journal>The Journal of clinical investigation</journal><pagination>e164303</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9711871</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Neutralizing antibody responses in patients hospitalized with SARS-CoV-2 Delta or Omicron infection.</pubmed_title><pmcid>PMC9711871</pmcid><funding_grant_id>P51OD011132,3U19AI057266-17S1,1U54CA260563,HHSN272201400004C,75N93021C00017</funding_grant_id><funding_grant_id>U01 HL122989-07</funding_grant_id><funding_grant_id>K08 AI141761</funding_grant_id><funding_grant_id>Emory Executive Vice President for Health Affairs Synergy Fund award,COVID-Catalyst-I3 Funds,2020 COVID-19 CURE Award.</funding_grant_id><pubmed_authors>Linderman SL</pubmed_authors><pubmed_authors>Mohr NM</pubmed_authors><pubmed_authors>Steingrub JS</pubmed_authors><pubmed_authors>Exline MC</pubmed_authors><pubmed_authors>Davis-Gardner ME</pubmed_authors><pubmed_authors>Chappell JD</pubmed_authors><pubmed_authors>Ahmed R</pubmed_authors><pubmed_authors>Gibbs KW</pubmed_authors><pubmed_authors>Bocangel Gamarra EL</pubmed_authors><pubmed_authors>Edupuganti S</pubmed_authors><pubmed_authors>Suthar MS</pubmed_authors><pubmed_authors>Tenforde MW</pubmed_authors><pubmed_authors>Surie D</pubmed_authors><pubmed_authors>Shapiro NI</pubmed_authors><pubmed_authors>Lauring AS</pubmed_authors><pubmed_authors>Lau MS</pubmed_authors><pubmed_authors>Qadir N</pubmed_authors><pubmed_authors>Self WH</pubmed_authors><pubmed_authors>Patel MM</pubmed_authors><pubmed_authors>Lai L</pubmed_authors><pubmed_authors>McElrath MJ</pubmed_authors><pubmed_authors>Frosch AE</pubmed_authors></additional><is_claimable>false</is_claimable><name>Neutralizing antibody responses in patients hospitalized with SARS-CoV-2 Delta or Omicron infection.</name><description/><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Dec</publication><modification>2025-04-26T05:14:24.175Z</modification><creation>2025-04-06T11:26:35.673Z</creation></dates><accession>S-EPMC9711871</accession><cross_references><pubmed>36256473</pubmed><doi>10.1172/JCI164303</doi></cross_references></HashMap>